MILANI, RODOLFO
 Distribuzione geografica
Continente #
NA - Nord America 10.005
AS - Asia 5.026
EU - Europa 3.950
SA - Sud America 704
AF - Africa 132
Continente sconosciuto - Info sul continente non disponibili 18
OC - Oceania 13
Totale 19.848
Nazione #
US - Stati Uniti d'America 9.757
SG - Singapore 1.783
CN - Cina 1.215
HK - Hong Kong 688
RU - Federazione Russa 639
VN - Vietnam 597
BR - Brasile 534
DE - Germania 517
SE - Svezia 510
UA - Ucraina 495
IE - Irlanda 452
IT - Italia 425
GB - Regno Unito 270
FR - Francia 197
IN - India 177
CA - Canada 173
FI - Finlandia 129
BD - Bangladesh 92
TR - Turchia 69
AT - Austria 58
IQ - Iraq 57
ZA - Sudafrica 53
NL - Olanda 50
MX - Messico 47
AR - Argentina 45
KR - Corea 44
PH - Filippine 44
ES - Italia 42
DK - Danimarca 41
JP - Giappone 38
SA - Arabia Saudita 38
EC - Ecuador 33
BE - Belgio 32
CO - Colombia 29
PL - Polonia 29
ID - Indonesia 28
PK - Pakistan 25
VE - Venezuela 20
UZ - Uzbekistan 18
MA - Marocco 17
PY - Paraguay 16
EU - Europa 14
MY - Malesia 14
TN - Tunisia 14
CZ - Repubblica Ceca 12
CH - Svizzera 11
IL - Israele 10
KE - Kenya 10
TH - Thailandia 10
AE - Emirati Arabi Uniti 9
CL - Cile 9
PE - Perù 9
IR - Iran 8
KZ - Kazakistan 8
AU - Australia 7
EG - Egitto 7
ET - Etiopia 7
JM - Giamaica 7
JO - Giordania 7
OM - Oman 7
PT - Portogallo 7
AL - Albania 6
CR - Costa Rica 5
NP - Nepal 5
RS - Serbia 5
AM - Armenia 4
AZ - Azerbaigian 4
DZ - Algeria 4
HU - Ungheria 4
LB - Libano 4
LT - Lituania 4
LV - Lettonia 4
BO - Bolivia 3
DO - Repubblica Dominicana 3
GY - Guiana 3
KW - Kuwait 3
PS - Palestinian Territory 3
QA - Qatar 3
SN - Senegal 3
TT - Trinidad e Tobago 3
TW - Taiwan 3
UY - Uruguay 3
AO - Angola 2
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
CG - Congo 2
GE - Georgia 2
GR - Grecia 2
HN - Honduras 2
KH - Cambogia 2
LK - Sri Lanka 2
LY - Libia 2
NG - Nigeria 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
RO - Romania 2
SC - Seychelles 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AP - ???statistics.table.value.countryCode.AP??? 1
BH - Bahrain 1
Totale 19.822
Città #
Ann Arbor 1.143
Singapore 1.040
Ashburn 878
Woodbridge 847
Hong Kong 660
Fairfield 643
Houston 611
San Jose 559
Chandler 545
Jacksonville 502
Dublin 425
Dearborn 328
Frankfurt am Main 291
Wilmington 285
New York 252
Seattle 241
Cambridge 234
Beijing 205
Princeton 194
Ho Chi Minh City 182
The Dalles 140
Hanoi 139
Los Angeles 138
Chicago 137
Nanjing 133
Santa Clara 125
Hefei 101
Milan 101
Dallas 90
Shanghai 90
Lachine 88
Lawrence 87
Altamura 85
Lauterbourg 80
Moscow 69
Boardman 63
Lissone 58
Buffalo 56
Vienna 55
São Paulo 53
Council Bluffs 51
Nanchang 45
London 41
Da Nang 38
San Diego 35
Seoul 34
Brussels 32
Shenyang 32
Guangzhou 31
Ottawa 31
Huizen 30
Andover 29
Munich 28
Changsha 27
Haiphong 27
Orem 26
Tokyo 26
Jiaxing 24
Rome 24
Helsinki 23
Baghdad 22
Johannesburg 22
Hebei 21
Falls Church 19
Jinan 19
Kunming 19
Washington 19
Chennai 18
Tianjin 18
Warsaw 18
Atlanta 17
Boston 17
Tashkent 17
Toronto 17
Turku 17
Denver 16
Manchester 16
Rio de Janeiro 16
Riyadh 16
Stockholm 16
Brooklyn 15
Fremont 15
Norwalk 15
Dhaka 14
Guayaquil 14
Mountain View 13
Phoenix 13
Belo Horizonte 12
Mexico 12
Montreal 12
Mumbai 12
Tampa 12
Brasília 11
City of London 11
Curitiba 11
New Delhi 10
Amsterdam 9
Biên Hòa 9
Düsseldorf 9
Nuremberg 9
Totale 13.185
Nome #
Stem cell augmented mesh materials: an in vitro and in vivo study 410
Staging of High-Risk Endometrial Cancer With PET/CT and Sentinel Lymph Node Mapping 383
Three-dimensional ultrasound assessment and middle term efficacy of a single-incision sling 374
Potential role of BCL2 in the recurrence of uterine smooth muscle tumors of uncertain malignant potential 370
Impact of Indocyanine Green for Sentinel Lymph Node Mapping in Early Stage Endometrial and Cervical Cancer: Comparison with Conventional Radiotracer 99mTc and/or Blue Dye 349
Histologic and metabolic assessment in a cohort of patients with genital prolapse: Preoperative stage and recurrence investigations 346
Long-term results of fertility-sparing treatment compared with standard radical surgery for early-stage epithelial ovarian cancer 340
Iliococcygeus fixation or abdominal sacral colpopexy for the treatment of vaginal vault prolapse: a retrospective cohort study 337
Incidence and risk factors of third- and fourth-degree perineal tears in a single Italian scenario 333
Preoperative staging of cervical cancer: is 18-FDG-PET/CT really effective in patients with early stage disease? 325
Randomized phase III clinical trial evaluating weekly cisplatin for advanced epithelial ovarian cancer 323
Better anatomical and cosmetic results using tunneled lotus petal flap for plastic reconstruction after demolitive surgery for vulvar malignancyc 315
Risk factors for persistent, de novo and overall overactive bladder syndrome after surgical prolapse repair 312
Transvaginal primary repair of a suprasphincteric rectovaginal fistula 304
Integration of hybrid single-photon emission computed tomography/computed tomography in the preoperative assessment of sentinel node in patients with cervical and endometrial cancer: Our experience and literature review 303
Preoperative 18F-FDG PET/CT in the management of advanced epithelial ovarian cancer 303
A prognostic regulatory pathway in stage I epithelial ovarian cancer: New hints for the poor prognosis assessment 298
The contribution of a collagen-fibrin patch (Tachosil) to prevent the postoperative lymphatic complications after groin lymphadenectomy: A double institution observational study 296
Optimizing strategies for sentinel lymph node mapping in early-stage cervical and endometrial cancer: Comparison of real-time fluorescence with indocyanine green and methylene blue 294
Conservative management of early-stage epithelial ovarian cancer: results of a large retrospective series 287
Sentinel Lymph Node Mapping With Near-Infrared Fluorescent Imaging Using Indocyanine Green: A New Tool for Laparoscopic Platform in Patients With Endometrial and Cervical Cancer 285
Near-Infrared Sentinel Lymph Node Mapping With Indocyanine Green Using the VITOM II ICG Exoscope for Open Surgery for Gynecologic Malignancies 277
Long-term clinical benefits of neoadjuvant chemotherapy in women with locally advanced cervical cancer: Validity of pathological response as surrogate endpoint of survival 274
Class II versus class III radical hysterectomy in stage IB-IIA cervical cancer: A prospective randomized study 272
The role of pelvic and aortic lymphadenectomy at second look surgery in apparent early stage ovarian cancer after inadequate surgical staging followed by adjuvant chemotherapy 263
Systematic lymphadenectomy in ovarian cancer at second-look surgery: a randomised clinical trial 253
Profiling cancer gene mutations in longitudinal epithelial ovarian cancer biopsies by targeted next-generation sequencing: a retrospective study 252
Resistance to platinum-based chemotherapy is associated with epithelial to mesenchymal transition in epithelial ovarian cancer 250
Delivery delay with neoadjuvant chemotherapy for cervical cancer patients during pregnancy: A series of nine cases and literature review 246
Long-term results of sequential postoperative treatment with vincristine, bleomycin, mitomycin c, cis-platin and radiotherapy after surgery for high-risk patients with cervical carcinoma stage IB-IIA 245
Primary insular carcinoid of the ovary with carcinoid heart disease: Unfavourable outcome of a case 244
The use of TachoSil for the prevention of postoperative complications after groin dissection in cases of gynecologic malignancy 243
Sentinel lymph node detection in endometrial cancer: hysteroscopic peritumoral versus cervical injection 242
Maximum standardized uptake value (SUVmax) as prognostic factor for surgical cytoreduction and response to adjuvant chemotherapy in women submitted to 18F-FDG PET/CT for staging of advanced epithelial ovarian cancer (aEOC) 241
Piperacillin versus cefotetan as single-dose prophylaxis in abdominal hysterectomy: A prospective, randomized, multicenter study 235
Prevention of postoperative urinary stress incontinence after surgery for genitourinary prolapse 233
Patient-derived ovarian tumor xenografts recapitulate human clinicopathology and genetic alterations 227
DNA-damage response gene polymorphisms and therapeutic outcomes in ovarian cancer 223
Comparison of flavoxate hydrochloride in daily dosages of 600 versus 1200 mg for the treatment of urgency and urge incontinence 219
Sulbactam/ampicillin versus cefotetan in the treatment of obstetric and gynecologic infections 219
Burch colposuspension versus modified Marshall-Marchetti-Krantz urethropexy for primary genuine stress urinary incontinence: a prospective, randomized clinical trial 218
Chromocystoscopy in the urological monitoring of patients with cancer of the cervix 213
Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer 210
Topical fenticonazole in dermatology and gynaecology: current role in therapy 208
Systematic lymphadenectomy at second look surgery in apparent early stage ovarian cancer after inadequate surgery and chemotherapy: a retrospective study 206
MiRNA landscape in stage I epithelial ovarian cancer defines the histotype specificities 205
A randomized comparison of continuous versus interrupted mass closure of midline incisions in patients with gynecologic cancer 202
Flavoxate hydrochloride for urinary urgency after pelvic radiotherapy: comparison of 600 mg versus 1200 mg daily dosages 201
Tumor volume calculation with VOCAL software in endometrial cancer patients: a reproducibility study 201
Double incontinence in urogynecologic practice: a new insight 191
Clinical evaluation of piperacillin in the treatment of severe infections in obstetrics and gynecology 188
Lymphadenectomy in uterine low-grade endometrial stromal sarcoma: an analysis of 19 cases and a literature review 187
Randomized study between radical surgery and radiotherapy for the treatment of stage IB–IIA cervical cancer: 20-year update 184
Embryo transfer following in vitro maturation and cryopreservation of oocytes recovered from antral follicles during conservative surgery for ovarian cancer 183
Modified radical hysterectomy versus extrafascial hysterectomy in the treatment of stage I endometrial cancer: results from the ILIADE randomized study 181
A double-blind trial of fentonium bromide in the treatment of incontinent unstable bladder 180
Total laparoscopic radical hysterectomy and pelvic lymphadenectomy in locally advanced stage IB2-IIB cervical cancer patients after neoadjuvant chemotherapy 179
The relationship of urethral resistance pressure and pressure flow parameters in women with lower urinary tract symptoms 178
Pefloxacin in the treatment of severe infections in gynecological cancer patients 178
Surgery for genitourinary prolapse and stress incontinence: a randomized trial of posterior pubourethral ligament plication and Pereyra suspension 177
Repair of the Perineal Defect After Radical Vulvar Surgery: Direct Closure Versus Skin Flaps Reconstruction: A Retrospective Comparative Study 177
Early diagnosis and prevention of female genital neoplasms in a clinic: preliminary evaluations 175
Reply to: Are the outcomes of neoadjuvant chemotherapy for stage Ib2 cervical cancer similar in pregnant and nonpregnant patients? 175
Solifenacin in the treatment of urgency and other symptoms of overactive bladder: results from a randomized, double-blind, placebo-controlled, rising-dose trial 170
Marshall-Marchetti-Krantz procedure and Burch colposuspension in the surgical treatment of female urinary incontinence 168
Sentinel node mapping in high risk endometrial cancer after laparoscopic supracervical hysterectomy with morcellation 168
Risk-assessment algorithm and recommendations for venous thromboembolism prophylaxis in medical patients 163
Effect of different gonadotrophin priming on IVM of oocytes from women with normal ovaries: a prospective randomized study 161
Platin-based chemotherapy and salvage surgery in recurrent ovarian cancer following negative second-look laparotomy 161
Identification of risk factors for genital prolapse recurrence 160
Cystometric evaluation of bladder function after radical hysterectomy 160
Significance of biopsy of the female vesical trigone 159
Vulvar endometriosis in surgical scar after excision of the Bartholin gland: report of a case 157
Functional and anatomical outcome of anterior and posterior vaginal prolapse repair with prolene mesh 156
Early and late pathology of the urinary tract after radical hysterectomy 154
Long-term prospective randomized study comparing two different regimens of oxybutynin as a treatment for detrusor overactivity 152
Anatomo-functional results of surgical repair of the urological complications following radiotherapy, surgery or combined therapy of cervical carcinoma 152
Efficacy of simplified bladder training in patients with overactive bladder receiving a solifenacin flexible-dose regimen: results from a randomized study 150
Hospital infections in obstetrics and gynecology 150
Urinary stress incontinence treatment with Remeex in a patient with epispadias: a case report 147
Patterns of constipation in urogynecology: clinical importance and pathophysiologic insights 146
Pressure flow study: a useful diagnostic test of female lower urinary tract symptoms 143
Major and minor urological complications after simple hysterectomy for malignant tumors of the female genital system 142
Ulipristal acetate versus leuprolide acetate for uterine fibroids 142
International Continence Society - 32nd Annual Meeting - Heidelberg, Germany - 28-30 August 2002 - Abstracts 140
Anomalie delle strutture di supporto della pelvi 137
Do overactive bladder symptoms improve after repair of anterior vaginal wall prolapse? 131
A case of laparoscopic uterosacral ligaments plication: a new conservative approach to uterine prolapse? 127
Overactive bladder syndrome: considerations in pharmacotherapy and new perspectives 126
Spontaneous uterine rupture in the third trimester of gestation after laparoscopic myomectomy. A case report 120
Anatomia funzionale del basso tratto urinario 113
Totale 20.097
Categoria #
all - tutte 65.851
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 65.851


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021254 0 0 0 0 0 0 0 0 0 159 45 50
2021/2022868 40 74 71 62 78 66 40 67 44 82 61 183
2022/20231.920 192 612 143 199 144 328 10 93 143 15 27 14
2023/20241.233 27 40 50 60 178 347 289 22 80 15 7 118
2024/20252.466 153 285 100 123 201 60 107 163 227 403 209 435
2025/20266.494 668 407 495 758 891 390 1.225 375 644 641 0 0
Totale 20.097